{"id":207840,"date":"2025-03-05T05:17:28","date_gmt":"2025-03-05T11:17:28","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2025\/03\/inflammation-identified-as-a-potential-cause-of-multiple-sclerosis-progression"},"modified":"2025-03-05T05:17:28","modified_gmt":"2025-03-05T11:17:28","slug":"inflammation-identified-as-a-potential-cause-of-multiple-sclerosis-progression","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2025\/03\/inflammation-identified-as-a-potential-cause-of-multiple-sclerosis-progression","title":{"rendered":"Inflammation identified as a potential cause of multiple sclerosis progression"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/inflammation-identified-as-a-potential-cause-of-multiple-sclerosis-progression2.jpg\"><\/a><\/p>\n<p>For the first time, researchers have identified that inflammation\u2014long associated with multiple sclerosis (MS)\u2014appears to cause increased mutations linked to MS progression.<\/p>\n<p>MS is a progressive neurological disease that affects 33,000 Australians and three million people worldwide. About one-third of people living with MS have progressive disease, which current treatments do not address effectively.<\/p>\n<p>The researchers studied MS brain lesions, visible as spots on MRI scans, which are areas of past or ongoing brain inflammation. They found <a href=\"https:\/\/medicalxpress.com\/tags\/neurons\/\" rel=\"tag\" class=\"\">neurons<\/a> located in MS brain lesions have a <a href=\"https:\/\/medicalxpress.com\/tags\/mutation+rate\/\" rel=\"tag\" class=\"\">mutation rate<\/a> that is two-and-a-half times faster than in normal neurons.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>For the first time, researchers have identified that inflammation\u2014long associated with multiple sclerosis (MS)\u2014appears to cause increased mutations linked to MS progression. MS is a progressive neurological disease that affects 33,000 Australians and three million people worldwide. About one-third of people living with MS have progressive disease, which current treatments do not address effectively. The [\u2026]<\/p>\n","protected":false},"author":427,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,47],"tags":[],"class_list":["post-207840","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/207840","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/427"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=207840"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/207840\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=207840"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=207840"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=207840"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}